This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Hearttransplantation is an effective treatment for end-stage heartdisease, and postoperative patients' medication adherence is crucial for transplantation outcomes and long-term survival.
Having explored how the heart is formed in utero, a researcher is reporting how cells and molecules act during that early formation and what might cause the heartdisease called left ventricular non-compaction or spongy heart, for which patients often require hearttransplants.
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in hearttransplantation, heart failure, and other complex cardiac conditions. Kobashigawa was instrumental in expanding the Comprehensive Transplant Program at Cedars-Sinai , one of the largest transplant programs in the world. “Dr.
Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. In a recent study, researchers tested a novel approach that involves injecting 'cardiac spheroids,' cultured from human stem cells, directly into damaged ventricles.
Adult patients surviving with congenital heartdisease (ACHD) is growing. We examine the factors associated with hearttransplant outcomes in this challenging population with complex anatomy requiring redo-sur.
New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heartdisease services and the specialist directed care.
This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Read more and share the research work at [link] Additionally, it offers comprehensive cardiac screening and preventive care.
Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone hearttransplant, or have Kawasaki disease or a congenital cardiovascular anomaly. All rights reserved.
Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early.
There is increased cognizance of gender inequality and the importance of inclusive and diverse approaches to medical research. Historically, women have been underrepresented in scientific fields, and this spills over into the research and study of women’s health.
Subscribe below to stay informed on the latest research and innovations in cardiometabolic care, including collaboration and partnership insights, ensuring you can seamlessly integrate these strategies into your practice. Key contributions: Advanced cardiac imaging (e.g.,
CAC detection is crucial for assessing cardiovascular risk, as CAC presence strongly correlates with coronary artery disease and related complications. Conducted at University Health Network, Dr. Patrik Rogalla’s research indicates that single exposure dual-energy imaging detects more CAC compared to traditional X-ray methods.
Atrial cardiomyopathy is a multifaceted heartdisease characterized by structural and functional abnormalities of the atria and is closely associated with atrial fibrillation and its complications. Its etiology involves a number of factors, including genetic, infectious, immunologic, and metabolic factors.
The hypothesis that a raised cholesterol level causes heartdisease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. And if you dare to suggest the idea that low-fat foods do not protect against heartdisease, you get much the same treatment.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content